MMP9 and myeloid sarcoma: Two different polymorphisms in the promoter region of the matrix metalloproteinase 9 (MMP9) gene are associated with higher MMP9 expression and, in MS cases, were reported to lower the age-of-onset [30], [31] however this effect was not replicated in another study [32].